23.45
Precedente Chiudi:
$23.75
Aprire:
$23.56
Volume 24 ore:
700.75K
Relative Volume:
0.84
Capitalizzazione di mercato:
$2.88B
Reddito:
$1.80B
Utile/perdita netta:
$15.62M
Rapporto P/E:
195.42
EPS:
0.12
Flusso di cassa netto:
$118.36M
1 W Prestazione:
+0.09%
1M Prestazione:
-5.48%
6M Prestazione:
-3.50%
1 anno Prestazione:
+8.11%
Privia Health Group Inc Stock (PRVA) Company Profile
Nome
Privia Health Group Inc
Settore
Industria
Telefono
571-366-8850
Indirizzo
950 N. GLEBE RD., SUITE 700, ARLINGTON
Confronta PRVA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
PRVA
Privia Health Group Inc
|
23.45 | 2.92B | 1.80B | 15.62M | 118.36M | 0.12 |
|
VEEV
Veeva Systems Inc
|
293.36 | 47.81B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
68.48 | 12.09B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
101.77 | 8.57B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
49.62 | 9.36B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
35.32 | 6.84B | 906.14M | -52.62M | 89.62M | -0.3621 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-10 | Iniziato | Needham | Buy |
| 2024-12-16 | Iniziato | Macquarie | Outperform |
| 2024-10-11 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Iniziato | Robert W. Baird | Outperform |
| 2024-04-22 | Iniziato | Citigroup | Buy |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2024-02-26 | Ripresa | Jefferies | Buy |
| 2024-02-22 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-12-06 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-06-13 | Iniziato | Evercore ISI | Outperform |
| 2023-04-12 | Iniziato | Stephens | Overweight |
| 2023-03-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-02-03 | Iniziato | Goldman | Buy |
| 2022-12-09 | Iniziato | Stifel | Buy |
| 2022-12-08 | Iniziato | UBS | Buy |
| 2022-09-07 | Ripresa | Truist | Buy |
| 2022-05-03 | Iniziato | BofA Securities | Buy |
| 2022-04-28 | Iniziato | BTIG Research | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2022-03-30 | Iniziato | Guggenheim | Buy |
| 2022-02-22 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2022-01-03 | Iniziato | Jefferies | Buy |
| 2021-09-27 | Iniziato | SVB Leerink | Outperform |
| 2021-09-10 | Iniziato | Cowen | Market Perform |
| 2021-05-24 | Iniziato | Canaccord Genuity | Buy |
| 2021-05-24 | Iniziato | Credit Suisse | Outperform |
| 2021-05-24 | Iniziato | JP Morgan | Overweight |
| 2021-05-24 | Iniziato | Piper Sandler | Overweight |
| 2021-05-24 | Iniziato | Truist | Buy |
| 2021-05-24 | Iniziato | William Blair | Outperform |
Mostra tutto
Privia Health Group Inc Borsa (PRVA) Ultime notizie
Can Privia Health Group Inc. stock maintain operating marginsMarket Performance Summary & Weekly Breakout Stock Alerts - newser.com
Tick level data insight on Privia Health Group Inc. volatilityJuly 2025 Sentiment & Daily Volume Surge Trade Alerts - newser.com
Multi asset correlation models including Privia Health Group Inc.Market Weekly Review & Reliable Volume Spike Trade Alerts - newser.com
How Privia Health Group Inc. stock performs in high volatility marketsJuly 2025 News Drivers & Expert-Curated Trade Recommendations - newser.com
How to manage a losing position in Privia Health Group Inc.2025 Retail Activity & Low Drawdown Trading Techniques - newser.com
Using data models to predict Privia Health Group Inc. stock movementDividend Hike & Consistent Profit Trading Strategies - newser.com
Full technical analysis of Privia Health Group Inc. stockJuly 2025 PreEarnings & Low Risk High Reward Ideas - newser.com
How institutional buying supports Privia Health Group Inc. stockTrade Entry Report & Weekly Chart Analysis and Guides - newser.com
Published on: 2025-11-14 03:13:09 - newser.com
Why Privia Health Group Inc. stock remains on buy listsJuly 2025 Price Swings & Verified Trade Idea Suggestions - newser.com
Can trapped investors hope for a rebound in Privia Health Group Inc. - newser.com
BMO Capital Initiates Coverage on Privia Health With Outperform Rating, $30 Price Target - MarketScreener
Solid Earnings Reflect Privia Health Group's (NASDAQ:PRVA) Strength As A Business - Yahoo Finance
BMO Capital Initiates Coverage on Privia Health (PRVA) with "Out - GuruFocus
5 Revealing Analyst Questions From Privia Health’s Q3 Earnings Call - Yahoo Finance
Privia Health stock price target raised to $34 from $32 at Canaccord Genuity - Investing.com Nigeria
Privia Health (PRVA) Target Price Increased by Canaccord Genuity - GuruFocus
Elevance Health, Labcorp, Privia Health, Fortrea, and Amgen Shares Are Soaring, What You Need To Know - The Globe and Mail
Understanding Privia Health Group Inc.’s price movementPortfolio Performance Report & Long Hold Capital Preservation Plans - newser.com
Privia Health Group, Inc. Experiences Revision in Its Stock Evaluation Amid Valuation Metrics - Markets Mojo
Truist Raises Price Target on Privia Health Group to $31 From $30, Keeps Buy Rating - MarketScreener
Truist Securities raises Privia Health stock price target to $31 on positive outlook - Investing.com Nigeria
Truist Securities raises Privia Health stock price target to $31 on positive outlook By Investing.com - Investing.com South Africa
Privia Health’s Earnings Call Highlights Robust Growth - The Globe and Mail
Privia Health Group, Inc. Hits New 52-Week High of $26.51 - Markets Mojo
Privia Health Group Inc Azioni (PRVA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):